IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
Clinical trial NCT06757881 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06757881
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2025-08-27
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.